Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?

類似資料

• Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
  著者:: Sami Morin-Ben Abdallah, 等
  出版事項: (2017-05-01)
• Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
  著者:: Morin-Ben Abdallah, Sami, 等
  出版事項: (2017)
• Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors
  著者:: Yun, Po-Jen, 等
  出版事項: (2019)
• Tyrosine Kinase Inhibitor Therapy for Brain Metastases in Non-Small-Cell Lung Cancer: A Primer for Radiologists
  著者:: Dodson, C., 等
  出版事項: (2020)
• Irreversible tyrosine kinase inhibition of epidermal growth factor receptor with afatinib in EGFR activating mutation–positive advanced non-small-cell lung cancer
  著者:: Abdallah, S. Morin–Ben, 等
  出版事項: (2018)